About Adaptive Biotechnologies Adaptive Biotechnologies is a commercial-stage biotechnology company focused on translating the genetic language of the adaptive immune system into clinical products to diagnose and treat disease. Quick Links Stock Governance Filings Press Releases Adaptive Biotechnologies Reports First Quarter 2026 Financial Results 05-05-2026 at 4:05 PM EDT Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026 04-15-2026 at 4:05 PM EDT Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results 02-05-2026 at 4:05 PM EST VIEW ALL NEWS Upcoming Events & Presentations More events are coming soon. Past Events & Presentations Adaptive Biotechnologies First Quarter Financial Results May 5, 2026 at 4:30 PM EDT Listen to webcast Adaptive Biotechnologies Q1 2026 Earnings Presentation 533.1 KB TD Cowen 46th Annual Healthcare Conference Mar 2, 2026 at 11:50 AM EST Listen to webcast Adaptive Biotechnologies Fourth Quarter Financial Results Feb 5, 2026 at 4:30 PM EST Listen to webcast Adaptive Biotechnologies Q4 and FY 2025 Earnings Presentation 856.2 KB VIEW ALL EVENTS CHANGE VOLUME 52 week high 52 week LOW MARKET CAP May 11, 2026 5:24 AM EDTData Provided by Refinitiv. Minimum 15 minutes delayed.
